XLO
Xilio Therapeutics, Inc. Common Stock
$8.79
0.00%
0.00
Notify me if price changes either direction
Buy XLO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
57.8M
Enterprise value
-91105848
Trailing PE
-2.0930767607859
Forward PE
-15.155172
PEG Ratio
0.027188419779281
Enterprise to EBITDA
2.23
Enterprise to revenue
-1.703
Price to book MRQ
1.1290945
Price to sales TTM
1.0806124
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
53.5M
EBITDA
-40855000
Diluted EPS TTM
-2.27
Total Cash (MRQ)
150.3M
Current ratio (MRQ)
3.59
Operating Cash Flow (TTM)
-56313000
XLO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
